NAMS vs CSQR Comparison

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Csquare Inc is an enterprise digital infrastructure platform, owning and operating a geographically diverse portfolio of carrier-neutral data centers located across the United States, Canada and the United Kingdom. The company provides carrier-neutral colocation and interconnection services that provide infrastructure, including space, power, cooling systems, physical security, and interconnection capabilities, enabling customers to deploy and operate IT and network infrastructure. Its facilities support enterprise, network, cloud, and technology customers in the deployment and operation of IT and network infrastructure. The company generates the majority of its revenue from enterprise colocation services, which include fees for the licensing of cabinet space and power.